CanSino Biologics Inc. (6185) has issued a notice confirming that its 2025 second extraordinary general meeting (EGM) is scheduled for November 27, 2025, at 2:00 p.m. at No. 1, Yuebin Hall, Hyatt Regency Tianjin East in Tianjin.

The EGM agenda focuses on several special and ordinary resolutions. Under special resolutions, proposals include canceling the Board of Supervisors and amending the Articles of Association, as well as related rules of procedure. Ordinary resolutions center on changes to key governance policies—covering management of raised funds, related party transactions, external guarantees, and external investments—as well as the terms of reference for independent non-executive directors. Additional motions include utilizing reserves to offset losses and appointing two new independent non-executive directors under a cumulative voting system.

According to the notice, shareholders may vote by poll according to listing regulations, and the chairman holds the authority to conduct a show of hands for procedural or administrative matters. Relevant forms and documents must be submitted to the designated share registrar for valid participation. The register of members of H shares will close on November 26 to 27, 2025, to determine attendance eligibility. A proxy need not be a shareholder, but the relevant proxy appointment documents must be lodged 24 hours before the EGM.